The Development of a Preclinical Alpha Irradiation Platform with Versatile Control of Dose, Dose Rate, and Spatiotemporal Irradiation Patterns

Objectives. This study develops and validates a vacuum-based alpha irradiation platform to support preclinical radiobiology. We aim to demonstrate precise, independent control over incident energy, fluence rate, and spatiotemporal patterns, which are critical to the mechanisms underlying targeted alpha therapies and low-dose risk assessments. Approach. A vacuum-based system with a radioactive alpha source was designed and fabricated. The platform provides independent modulation of: (i) temporal patterns via a programmable gate valve; (ii) fluence rate across two orders of magnitude by varying source-to-aperture distance (57 to 381 mm); (iii) incident energy (0 to 4.6 MeV) using adjustable absorption layers; and (iv) spatial distributions via a 3D motion stage. Temporal precision was assessed via synchronized audio-electronic recordings. Fluence rates and energies were validated using CR-39 detectors and Monte Carlo (MC) simulations. Spatial precision was verified through programmed continuous and discrete trajectories. Main results. Validation experiments demonstrated high system fidelity. Measured irradiation durations deviated from programmed values by less than 0.3 s. Measured and computed fluence rates agreed within 3%. For energy validation, CR-39 track diameters matched MC model predictions within one standard deviation. Recorded spatial patterns and dimensions aligned well with programmed trajectories. Significance. We successfully validated a versatile vacuum-based platform that overcomes energy-degradation constraints of gas-filled systems. By providing multi-parametric control over alpha-particle delivery, this system enables systematic investigation into how energy, dose rate, and spatiotemporal patterns influence radiobiological responses. This platform is poised to optimize targeted alpha therapies and refine radiation protection frameworks.

💡 Research Summary

The authors present a newly engineered vacuum‑based alpha‑irradiation platform designed for pre‑clinical radiobiology studies, and they rigorously validate its ability to independently control four key physical parameters: temporal exposure pattern, fluence rate, incident particle energy, and spatial dose distribution. The system incorporates an Am‑241 alpha source (4.8 MBq) housed in a stainless‑steel vacuum chamber (10 in × 7 in × 7 in) pumped down to a base pressure of 2 × 10⁻³ hPa using a Pfeiffer HiScroll 12 backing pump. Energy degradation is essentially eliminated because the source‑to‑exit‑window path is maintained under high vacuum; the only energy‑modifying elements are a thin (2 µm) gold coating on the source, a silicon‑nitride exit window (few hundred nanometers thick), and a controllable air gap. By varying the thickness of additional absorber layers, the incident energy at the sample plane can be tuned continuously from essentially zero up to 4.6 MeV, covering the full spectrum of biologically relevant alpha energies.

Temporal control is achieved with a pneumatic gate valve (VA‑T Series 10.8 UHV) actuated by a solenoid driven by a Raspberry Pi microcontroller. The valve can be opened for preset durations (5, 10, 15 s) with a measured deviation of less than 0.3 s, as confirmed by synchronized audio recordings of a Geiger–Müller counter and high‑speed video. An emergency‑shutdown mode, triggered by an acoustic sensor, demonstrates sub‑second response times, ensuring safe operation.

Fluence rate modulation relies on adjusting the source‑to‑aperture distance between 57 mm and 381 mm using a linear manipulator with 1 mm precision. This geometric change yields a two‑order‑of‑magnitude span in particle fluence (≈10⁻² mm⁻²·s⁻¹ to 10⁰ mm⁻²·s⁻¹). Theoretical fluence values derived from a simple geometric model (activity, source area, aperture area, distance) match experimental CR‑39 track counts within 3 %, confirming the reliability of the calculation.

Spatial patterning is provided by a custom 3‑axis motion stage (X/Y 120 mm, Z 50 mm travel) driven by NEMA‑17 and NEMA‑14 stepper motors, also controlled via the Raspberry Pi. The stage can execute programmed continuous trajectories (circles, spirals, raster scans) as well as discrete point arrays. CR‑39 detectors placed at the sample plane record track distributions that faithfully reproduce the programmed patterns, demonstrating sub‑10 µm positioning accuracy.

Physical validation of particle energy uses CR‑39 track diameter analysis after chemical etching. Track radii correlate with incident alpha energy; measured diameters agree with Geant4 Monte Carlo simulations of the source, gold coating, and absorber stack within one standard deviation. Energy loss in the vacuum path is negligible (<0.1 %) even at the highest pressure tested (10⁻¹ hPa).

Overall, the platform delivers a highly reproducible, multi‑parameter irradiation environment free from the energy‑loss constraints of traditional gas‑filled alpha sources. This capability enables systematic investigations of dose‑rate effects, low‑dose hypersensitivity, bystander signaling, and oxygen‑modulated responses—areas where current radiobiological models assume dose‑rate independence for high‑LET radiation. By providing independent, precise control of energy, fluence, timing, and geometry, the system is poised to accelerate optimization of targeted alpha therapies (TAT, DART) and to refine radiation protection guidelines for low‑dose alpha exposure. Future work will likely integrate biological endpoints (DNA damage assays, clonogenic survival, signaling biomarkers) to directly link the engineered physical parameters with cellular outcomes, thereby bridging a critical gap between physics and radiobiology.